Motonari Uesugi Selected Research

adamanolol

4/2003

A gene-expression inhibitor that targets an alpha-helix-mediated protein interaction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Motonari Uesugi Research Topics

Disease

10	Neoplasms (Cancer) 12/2022 - 10/2002
3	Breast Neoplasms (Breast Cancer) 01/2016 - 10/2002
2	Heart Diseases (Heart Disease) 01/2021 - 11/2012
1	Carcinogenesis 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Hypercalcemia (Milk Alkali Syndrome) 01/2021
1	Williams Syndrome (Williams-Beuren Syndrome) 01/2021
1	Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy) 01/2021
1	Hypertension (High Blood Pressure) 01/2020
1	Cardiac Arrhythmias (Arrythmia) 01/2019
1	Atrophy 07/2018
1	Secondary Hyperparathyroidism 01/2018
1	Metabolic Diseases (Metabolic Disease) 02/2017
1	Myocardial Infarction 01/2017
1	Diabetes Mellitus 02/2014
1	Glioblastoma (Glioblastoma Multiforme) 07/2013
1	Glioma (Gliomas) 07/2013
1	Starvation 08/2011
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2011
1	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 01/2011
1	Fibrosarcoma 08/2010
1	Neoplasm Metastasis (Metastasis) 08/2010
1	Body Weight (Weight, Body) 08/2009
1	Prostatic Neoplasms (Prostate Cancer) 03/2006
1	Hepatocellular Carcinoma (Hepatoma) 03/2006

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 12/2022 - 10/2002
4	Transcription Factors (Transcription Factor)IBA 01/2021 - 10/2002
3	Pharmaceutical PreparationsIBA 01/2020 - 01/2018
2	Messenger RNA (mRNA)IBA 12/2022 - 01/2016
2	Vitamin D3 24-HydroxylaseIBA 01/2021 - 01/2018
2	Vitamin D FDA LinkGeneric 01/2021 - 02/2017
2	ProhibitinsIBA 01/2018 - 01/2011
1	5' Untranslated Regions (5' UTR)IBA 12/2022
1	SREBP cleavage-activating proteinIBA 01/2022
1	Sterol Regulatory Element Binding ProteinsIBA 01/2022
1	sodium phosphate (trisodium phosphate)FDA LinkGeneric 01/2021
1	hydroxide ionIBA 01/2021
1	KY02111IBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Farnesyl-Diphosphate Farnesyltransferase (Squalene Synthase)IBA 01/2021
1	SymportersIBA 01/2021
1	Glycine Receptors (Glycine Receptor)IBA 01/2020
1	Niflumic AcidIBA 01/2020
1	Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA 01/2019
1	Terfenadine (Seldane)IBA 01/2019
1	Irinotecan (Camptosar)FDA LinkGeneric 02/2018
1	26,26,26,27,27,27- hexafluoro- 1,25- dihydroxyvitamin D3IBA 01/2018
1	LipidsIBA 02/2017
1	matrigelIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2016
1	Insulin (Novolin)FDA Link 02/2014
1	TubulinIBA 12/2013
1	PlasticsIBA 07/2013
1	Polycomb Repressive Complex 2IBA 07/2013
1	Biological ProductsIBA 07/2013
1	ChromatinIBA 07/2013
1	Amino Acids FDA Link 08/2011
1	Superoxide Dismutase-1IBA 04/2011
1	aurilideIBA 01/2011
1	Matrix Metalloproteinases (MMPs)IBA 08/2010
1	Disulfiram (Antabuse)FDA Link 08/2010
1	Blood Glucose (Blood Sugar)IBA 08/2009
1	fatostatinIBA 08/2009
1	Insulin-Like PeptidesIBA 03/2006
1	chromeceptinIBA 03/2006
1	MitogensIBA 03/2006
1	Nuclear Proteins (Protein, Nuclear)IBA 04/2003
1	Mediator ComplexIBA 04/2003
1	adamanololIBA 04/2003
1	CytokinesIBA 02/2003
1	Glucose (Dextrose)FDA LinkGeneric 02/2003
1	Oncogene Proteins (Oncogene Protein)IBA 10/2002
1	Peptides (Polypeptides)IBA 10/2002

Therapy/Procedure

4	Therapeutics 02/2014 - 08/2010
1	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2021
1	Drug Therapy (Chemotherapy) 12/2013